1. Home
  2. YMAB vs JAKK Comparison

YMAB vs JAKK Comparison

Compare YMAB & JAKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • JAKK
  • Stock Information
  • Founded
  • YMAB 2015
  • JAKK 1995
  • Country
  • YMAB United States
  • JAKK United States
  • Employees
  • YMAB N/A
  • JAKK N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • JAKK Recreational Games/Products/Toys
  • Sector
  • YMAB Health Care
  • JAKK Consumer Discretionary
  • Exchange
  • YMAB Nasdaq
  • JAKK Nasdaq
  • Market Cap
  • YMAB 192.4M
  • JAKK 216.9M
  • IPO Year
  • YMAB 2018
  • JAKK 1996
  • Fundamental
  • Price
  • YMAB $4.60
  • JAKK $20.13
  • Analyst Decision
  • YMAB Buy
  • JAKK Strong Buy
  • Analyst Count
  • YMAB 11
  • JAKK 4
  • Target Price
  • YMAB $17.55
  • JAKK $41.75
  • AVG Volume (30 Days)
  • YMAB 226.0K
  • JAKK 160.8K
  • Earning Date
  • YMAB 05-13-2025
  • JAKK 04-29-2025
  • Dividend Yield
  • YMAB N/A
  • JAKK 2.48%
  • EPS Growth
  • YMAB N/A
  • JAKK 47.04
  • EPS
  • YMAB N/A
  • JAKK 4.03
  • Revenue
  • YMAB $88,658,000.00
  • JAKK $714,219,000.00
  • Revenue This Year
  • YMAB N/A
  • JAKK N/A
  • Revenue Next Year
  • YMAB $16.03
  • JAKK $3.89
  • P/E Ratio
  • YMAB N/A
  • JAKK $4.99
  • Revenue Growth
  • YMAB 4.92
  • JAKK 2.89
  • 52 Week Low
  • YMAB $3.55
  • JAKK $17.06
  • 52 Week High
  • YMAB $16.11
  • JAKK $35.79
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 56.43
  • JAKK 47.29
  • Support Level
  • YMAB $3.99
  • JAKK $19.62
  • Resistance Level
  • YMAB $5.00
  • JAKK $21.61
  • Average True Range (ATR)
  • YMAB 0.35
  • JAKK 0.94
  • MACD
  • YMAB 0.10
  • JAKK 0.03
  • Stochastic Oscillator
  • YMAB 70.47
  • JAKK 13.67

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About JAKK JAKKS Pacific Inc.

Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.

Share on Social Networks: